Dexcom vs FreeStyle Libre: Which CGM Is Right for You? (2026)

If you are shopping for a continuous glucose monitor in 2026, the decision almost always comes down to two names: Dexcom and FreeStyle Libre. Both are excellent. Both have transformed how people manage diabetes. But they are built around different philosophies, and the right one for you depends entirely on how you live and what you need from a sensor. Here is an honest, side-by-side look — with no brand-bashing in either direction.

First, What a CGM Actually Does

A continuous glucose monitor is a small wearable sensor that measures the glucose in the fluid just beneath your skin and sends a reading to your phone every few minutes, around the clock. Instead of pricking your finger several times a day and seeing isolated snapshots, you get a continuous trend line — where your glucose is now, where it has been, and which direction it is heading.

That continuous view is the whole point. It lets you catch a low before it becomes dangerous, see how a particular meal affects you, and understand your overnight patterns — the hours you would otherwise be flying blind. For many people with Type 1 or insulin-using Type 2 diabetes, a CGM is genuinely life-changing. And increasingly, people with non-insulin Type 2 and even those without diabetes use them to understand their metabolism.

Today, the two dominant consumer CGMs are the Dexcom G7 and the FreeStyle Libre 3 (and its Plus variant). Both are tiny, both stream data to your phone, and both are accurate enough to make real decisions on. The differences are in the details — and the details matter.

Dexcom G7

What it does well

Dexcom built its reputation on real-time alerts and alarms, and the G7 is the high-water mark for that philosophy. You set a low threshold and a high threshold, and the sensor will alert you the moment you cross them — even waking you from sleep. There is a dedicated, non-silenceable urgent low alarm at 55 mg/dL that is specifically designed to cut through everything, which is a meaningful safety feature for anyone prone to hypoglycemia.

The G7 also offers a predictive low alert — it can warn you up to 20 minutes before you are projected to go low, giving you a head start to grab carbs before things get bad. For people with hypoglycemia unawareness, that early warning can be the difference between a quick snack and a serious episode.

Dexcom's sharing and follow ecosystem is mature and reliable. Through the Dexcom Follow app, up to ten followers — partners, parents, caregivers — can see your glucose in real time with their own alert thresholds. There is also strong smartwatch support, including a standalone Apple Watch path that can receive readings directly. And the G7 is the sensor most deeply integrated with automated insulin delivery (AID) systems from Tandem, Insulet, and others, making it the default choice if you use or plan to use a closed-loop pump.

What is worth weighing

The trade-off for all that capability is that the G7 system is generally more expensive and leans toward people who want active management. The standard wear time is about 10 days plus a short grace period, which is solid but shorter than Libre's. And while the alerts are a strength, some users find the alarm frequency overwhelming at first and need time to tune their thresholds so they are not buzzing constantly.

The G7 also requires the transmitter electronics to be part of each disposable sensor, which is convenient (nothing to reuse or recharge) but contributes to the cost structure.

FreeStyle Libre 3

What it does well

Abbott's FreeStyle Libre line earned its huge user base on simplicity, comfort, and accessibility, and the Libre 3 carries that forward. The sensor is famously small — roughly the size of two stacked coins, and one of the most discreet CGMs on the market. Application is quick and nearly painless with a single-piece applicator.

The headline number is wear time: a Libre 3 sensor lasts up to 14 days, the longest of the mainstream options. Fewer sensor changes means less hassle and, often, a lower overall cost. Like the G7, the Libre 3 now streams readings continuously to your phone in real time (earlier Libre generations required you to scan the sensor, but that limitation is gone).

The Libre 3 also added optional real-time alarms, including a low-glucose alarm, which closed what used to be the biggest gap between Libre and Dexcom. And critically, Libre tends to be the more budget-friendly and broadly accessible option — it is frequently covered more generously, has a lower cash price in many regions, and is often the first CGM offered to people with Type 2 diabetes. For a lot of people, Libre is simply the easiest CGM to actually get and afford.

What is worth weighing

The Libre 3's warm-up period is about an hour — longer than the G7's 30 minutes, though still far shorter than legacy sensors. Its alarm and predictive-alert system, while much improved, is generally considered a step behind Dexcom's for people who lean heavily on aggressive low-prediction and customizable, escalating alerts.

Sharing exists through Abbott's LibreLinkUp app, and it works, but Dexcom's follower ecosystem is generally regarded as more polished and feature-rich for caregivers monitoring multiple thresholds. And historically, the Libre has had narrower compatibility with automated insulin delivery systems, though that landscape is expanding.

Head-to-Head Comparison

Here is how the two sensors stack up across the categories that matter most. Specifics can shift with new firmware and regional versions, so treat this as a general guide rather than a spec sheet:

A quick word on accuracy: both sensors post single-digit MARD scores (mean absolute relative difference — lower is better), putting them in the same elite tier. In real-world use, the difference between them is small enough that for most people it should not be the deciding factor. Both are accurate enough to dose insulin on per their respective labeling, and both can show occasional discrepancies during rapid glucose swings or in the first hours after application. Individual bodies also vary — some people simply run more accurately on one sensor than the other.

How to Choose: Match the Sensor to Your Life

Rather than asking "which is better," the more useful question is "which fits how I actually live?" Here is how to think about it by use case.

Choose Dexcom G7 if you want tight control and robust alarms

If you have Type 1 diabetes, experience hypoglycemia unawareness, or simply want the most aggressive safety net of alerts and predictions, the G7 is hard to beat. The same is true if you use or plan to use an automated insulin delivery pump — Dexcom's broad AID integration makes it the natural choice for closed-loop systems. And if you rely on caregivers or family monitoring your glucose closely, Dexcom's mature follower ecosystem and Apple Watch support are real advantages. The fastest warm-up is a nice bonus for anyone who changes sensors and wants data back quickly.

Choose FreeStyle Libre 3 if you value simplicity, comfort, and cost

If you are newer to CGMs, have Type 2 diabetes, or want a sensor that mostly stays out of your way, Libre's long 14-day wear, tiny footprint, and easy application make it a fantastic everyday companion. It is also frequently the more accessible and affordable option, which is no small thing — the best CGM is the one you can consistently afford to keep wearing. If you do not need the most aggressive alarm system and just want reliable, comfortable, continuous data, Libre delivers beautifully.

Both Write to Apple Health — and That Changes Everything

Here is the detail that often gets lost in these comparisons: both Dexcom and FreeStyle Libre write their glucose data to Apple Health. Whichever sensor you choose, your readings flow into the same central health hub on your iPhone. That means you are not locked into one manufacturer's app to make sense of your numbers.

This matters because, honestly, neither the Dexcom app nor the Libre app was designed to be your full diabetes-management home base. They are excellent at displaying glucose and firing alarms. But they do not know what you ate, how many carbs you counted, how much insulin you took, or what your week actually looked like. Your glucose trace is the output — the inputs that drive it live somewhere else.

That is where a companion app earns its place on your home screen. SweetLife, for example, pulls glucose data through Apple HealthKit, so it works seamlessly whether you wear a Dexcom or a Libre. On top of that glucose layer, it adds meal tracking with carb counting, insulin logging, an AI assistant for quick questions about food and dosing, trend insights that connect meals to spikes, and family sharing that works regardless of which sensor brand each person wears.

The goal is not to replace your CGM app — you will still use Dexcom or Libre for live readings and alarms. The goal is to fill the gap between "here is your glucose" and "here is what to do about it." Because the meal-to-spike connection, the insulin-timing patterns, and the weekly story of your management only emerge when you combine glucose with everything else going on in your life. And since SweetLife sits on top of Apple Health, you get that context layer no matter which sensor you ultimately choose.

The Bottom Line

Dexcom G7 and FreeStyle Libre 3 are both outstanding continuous glucose monitors, and you genuinely cannot make a bad choice between them. Reach for the Dexcom G7 if you want the most robust alarms, the strongest predictive alerts, the fastest warm-up, and the deepest pump integration. Reach for the FreeStyle Libre 3 if you prioritize long 14-day wear, a tiny discreet sensor, and broader affordability and access.

Whichever you pick, remember that the sensor is only half the equation. Pair it with a companion app that layers your meals, insulin, and daily life on top of that glucose data, and you turn a stream of numbers into something you can actually act on. That is the setup that makes the biggest difference — the right sensor for your life, plus the context to understand it.